by MVG Consulting | Jan 14, 2022 | Clinical Trials, Company News, Industry News
One of the most important and often under-resourced aspects of clinical trials is vendor selection, management and oversight. If vendor management isn’t a top priority, it should be, as the FDA places large significance on this area, as is evidenced by the most recent...
by MVG Consulting | Jan 7, 2022 | Clinical Trials, Company News, Featured
The ICH E6 Good Clinical Practice (GCP) Guideline, the current global standard for clinical trials, is estimated to have its public draft version of the third revision (known as “R3”) published this month, January of 2022. The primary change that can be expected in...
